FindTrial
Sign In

Homoeopathy for Erectile Dysfunction: Individualized Treatment Study.

The Effectiveness of Individualized Homoeopathic Remedies selected using Boger Boenninghausens Characteristics & Repertory in Erectile Dysfunction: An Open label Prospective Clinical Study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/03/064462
Enrollment
40
Registered
2024-03-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N528- Other male erectile dysfunction

Interventions

Intervention1: Individualized Homoeopathic Remedy: a) Individualized Homoeopathic Remedy selected using Boger Boenninghausens Characteristics & Repertory b) Remedies selected will be prescribed in Cen

Sponsors

Kothapally Sugnan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects of all socio-economic status and all religions. 2. Clinically diagnosed cases of erectile dysfunction using the International Index of Erectile Function (IIEF-5) questionnaire. 3. Willingness to actively participate in the study, attend regular follow-up assessments, and adhere to the prescribed homeopathic treatment plan. 4. literate patients who can read Hindi, English, or Bengali and can self-assess the questionnaire will be considered. 5. Patients who have already had other method of treatment but now intend to undergo homoeopathic treatment, after providing a gap of four weeks as wash-out period 6. No homeopathic treatment for any ailment including erectile dysfunction within the past 2 months. 7. Stable overall health without acute or severe medical conditions.

Exclusion criteria

Exclusion criteria: 1. Severe cardiovascular diseases, such as uncontrolled hypertension or recent myocardial infarction. 2. Current suffering from severe, acute, life-threatening illnesses or Psychiatric conditions 3. Patients with congenital genital defects. 4. Pelvic or genital surgery within the past six months. 5. Current use of phosphodiesterase type 5 (PDE5) inhibitors for erectile dysfunction 6. Inability or unwillingness to comply with scheduled follow-up visits and assessment.

Design outcomes

Primary

MeasureTime frame
Assessment of the impact of Homoeopathic treatment on the symptoms and severity of Erectile Dysfunction, utilizing the IIEF-5 questionnaire.Timepoint: Baseline and 6th month—

Secondary

MeasureTime frame
assessment of the overall improvement in quality of life following Homoeopathic interventions, measured through the 36-Item Short Form Survey Instrument (SF-36)Timepoint: Baseline and 6th month—

Countries

India

Contacts

Public ContactDr. Avijit Shee Burman.

National Institute of Homoeopathy

asheeburman@gmail.com9433392108

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026